Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 0.4171
-7.06 %
$ 12.5 M
Market Cap
-0.27
P/E
PRPH - RESEARCH & DEVELOPMENT
Research & Development PRPH - ProPhase Labs, Inc.
1.42 M
LAST VALUE
65.13%
2 YEAR CAGR
28.93%
5 YEAR CAGR
5.58%
10 YEAR CAGR